As of 2025-07-12, the Fair Value of Adverum Biotechnologies Inc (ADVM) is -30.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.54 USD, the upside of Adverum Biotechnologies Inc is -1,311.51%.
With the market price of 2.54 USD and our fair value calculation, Adverum Biotechnologies Inc (ADVM) is not a good investment. Investing in ADVM stocks now will result in a potential loss of 1,311.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -117.51 | -145.54 | -154.54 | -117.17 | -130.93 | -133.13 |
| YoY growth | -82.22% | -23.86% | -6.18% | 24.18% | -11.75% | -19.96% |
| Market Cap (mil) | 53.06 |
| P/E | |
| Forward P/E |
| EPS | -6.15 |
| Avg earnings growth rate | -19.96% |
| TTM earnings | -128.57 |